Previous 10 | Next 10 |
A very quiet and tasteful way to be famous is to have a famous relative. Then you can not only be nothing, you can do nothing too ."- P. J. O'Rourke It was a wild week for investors as the markets went through their most volatile week of trading since the 2008 financial crisis. Sports lea...
DUBLIN, Ireland and BRIDGEWATER, N.J., March 15, 2020 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a leader in preventative cardiovascular risk reduction therapy, today announced actions in support of public health initiatives to combat the COVID-19 pandemic. The COVID-19 pa...
IDEAYA Biosciences (NASDAQ: IDYA ) initiated with Buy rating and $12 (192% upside) price target at Roth Capital. More news on: IDEAYA Biosciences, Inc., Menlo Therapeutics Inc., Amarin Corporation plc, Healthcare stocks news, Stocks on the move, , Read more ...
No one can predict the future. Attempting to decipher whether yesterday's 2,013-point plunge in the Dow Jones Industrial Average was an aberration or the start of a new bear market is essentially a waste of time. What we do know for sure is that the U.S. stock markets will eventually reco...
Amarin (AMRN) has made a poor show despite a major label expansion last year, and the coronavirus panic has taken it down almost 20% in the last few trading days. While expected solid earnings over the next few quarters are going to be able to bring the stock back up slowly, investors need to ...
Shares of mid-cap drugmaker Amarin (NASDAQ: AMRN) fell by 20.9% in February, according to data from S&P Global Market Intelligence . The Irish biopharma hit the skids last month for two reasons. First, investors apparently weren't entirely enthused with Amarin's fourth-...
Who doesn't love a good sale? With the markets in turmoil and little idea when it will end, healthcare investors can seize the opportunity to snap up discounted shares of quality companies. Here, I explore six attractive small and mid-cap biotechs with valuations greater than $5.5 billion. Thes...
"But in college, we can wear our alcohol abuse as proudly as our university sweatshirts; the two concepts are virtually synonymous. ”― Koren Zailckas, Smashed: Story of a Drunken Girlhood The older I get the more often I find myself missing the simplicity of my youth. This i...
The following slide deck was published by Amarin Corporation plc in conjunction with their 2019 Q4 earnings Read more ...
Anaplan (NYSE: PLAN ) -29% despite Q4 beat . More news on: Anaplan, Inc., Continental Resources, Inc., Nutanix, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2024 results followed ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...